The global softgel capsules market is projected to reach USD 1.5 billion by 2028 from USD 1.1 billion in 2023, at a CAGR of 6.3% during the forecast period. The growth of this market is majorly driven by the benefits of softgel capsules, increasing demand for dietary supplements and nutraceuticals, and rising demand for naturally sourced ingredients. On the other hand, limited acceptance due to cultural restrictions is expected to hinder the growth of this market.
The global softgel capsules market is competitive, with large, medium-sized, and small market players. The global softgel capsules market was dominated by Gelita AG (Germany), PB Leiner (Part of Tessenderlo Group) (Belgium), and Darling Ingredients Inc. (US).
To know about the assumptions considered for the study download the pdf brochure
DARLING INGREDIENTS INC. (US)
Darlings Ingredients is one of the leading providers of softgel capsules. The company’s focus on launching innovative products and technologies to back its existing product portfolio makes it a leading player in the market. The company also focuses on expanding its geographic footprint and increasing its global manufacturing capacity of pharmaceutical gelatin. Rousselot brand has launched pharmaceutical-grade, modified gelatin, i.e., X-Pure GelDAT – Gelatin Desaminotyrosine for biomedical applications. The company’s wide presence worldwide has also played an important role in securing its position in the market. To maintain its leading position and enhance its market share, the company mainly focuses on exceeding customer expectations by maintaining the quality of its services and quickly & efficiently adapting to new conditions.
GELITA AG (GERMANY)
Gelita AG is one of the leading manufacturers of gelatin, collagen peptides for food, health & nutrition, pharmaceutical, and other applications across various industries. Gelita supplies tailor-made gelatines. The company has around 22 production plants and 4 sales offices globally. Gelita AG maintains its dominant position by having a strong & diversified distribution channel and customer base. Focus on the launch of novel products is likely to impact the company’s market position positively. Strong emphasis on acquisitions of smaller players operating in the gelatin market coupled with geographical expansions will help the company retain its dominant position in the market.
PB LEINER (PART OF TESSENDERLO GROUP) (BELGIUM)
Tessenderlo Group is the leading provider of softgels for the pharmaceutical, biopharmaceutical, and nutraceutical industries. Tessenderlo Group’s business activities are divided into four operating segments, namely, Agro, Bio-valorization, Industrial Solutions, and T-Power. The animal by-product processing activities of Tessenderlo Group are combined in the Bio-valorization segment across its brands, PB Leiner and Akiolis. The company deals with softgels through its brand, PB Leiner, which provides a complete range of high-quality gelatin for pharmaceutical applications. The company maintains its position in the market by strategically adopting strong organic strategies and acquisitions in the softgel capsules market. The company has a wide product portfolio in the softgel capsules market. This indicates the company’s focused strategy to emerge as a leader in the market in the coming years.
Softgel Capsules Market by Material, Source (Porcine, Bovine), Application (Pharmaceuticals, Nutraceuticals & Dietary Supplements, Cosmetics & Personal Care), Region(North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE